Barusiban

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBarusiban
Drug Alias Name巴芦西班barusiban巴卢西班barusibanumFE-200440
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionOxytocin receptor antagonists
TargetsOxytocin receptor
Therapy Area/IndicationsPremature BirthObstetric Labor, PrematureInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[9] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFerring Bv
Active IndicationsN/A
Inactive IndicationsPremature BirthObstetric Labor, PrematureInfertility

Other Information

ATC CodeN/A
Related LinksWikipedia